SHPH: Shuttle Pharmaceuticals Holdings, Inc. Stock

by  •  • Comments Off on SHPH: Shuttle Pharmaceuticals Holdings, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 1.49
Enterprise Value ($M) -1.52
Book Value ($M) 3.29
Book Value / Share 0.52
Price / Book 0.45
NCAV ($M) 2.93
NCAV / Share 0.47
Price / NCAV 0.51

Profitability (mra)
Return on Invested Capital (ROIC) -2.06
Return on Assets (ROA) -2.20
Return on Equity (ROE) -3.79

Liquidity (mrq)
Quick Ratio 2.78
Current Ratio 2.78

Balance Sheet (mrq) ($M)
Current Assets 4.96
Assets 5.31
Liabilities 2.02
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -7.70
Net Income -9.14

Cash Flow Statement (mra) ($M)
Cash From Operations -7.33
Cash from Investing 2.92
Cash from Financing 3.76

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G Armistice Capital, Llc 7.51

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2025-02-26 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-09-04 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-09-04 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1)
2024-09-04 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1)

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-14 3,061,564 9,040,699 33.86
2025-05-13 510,511 2,499,169 20.43
2025-05-12 2,519,989 8,187,014 30.78
2025-05-09 21,763,481 76,343,249 28.51

(click for more detail)

Similar Companies
SBFM – Sunshine Biopharma, Inc. SCLX – Scilex Holding Company
SGMO – Sangamo Therapeutics, Inc. SILO – Silo Pharma, Inc.
SLGL – Sol-Gel Technologies Ltd.


Financial data and stock pages provided by
Fintel.io